As we enter the winter flu season, embracing more innovative diagnostics at the point of care (POC) could play a vital role in helping to address the burden which influenza places on public health services. Read more


Biotechnology company, BioNTech, has entered into a multi-year research and development (R&D) collaboration with Pfizer for the development of mRNA-based vaccines for the prevention of influenza (flu). Read more


New diagnostic technology set to play an important part in improving the quality of testing for influenza in order to meet new US Food and Drug Administration (FDA) criteria. Read more


As we approach World Health Day (7 April), which this year coincides with the 70th anniversary year of WHO and has a focus on ‘health for all’, we take a look at some key topics that have impacted pharma over the past six months… Read more